CME and CFTC Locked in Battle Over On-Chain Perpetual Futures

The rift between the CME Group, the largest derivatives exchange operator in the US, and its regulator, the Commodity Futures Trading Commission, has deepened over the agency's decision to allow blockchain-based perpetual futures products. The CME has taken the CFTC to court, challenging its decision to permit the listing of crypto perpetual futures by platforms such as Kalshi and Coinbase. At the heart of the dispute is the CME's claim that these products are being mislabeled and that the CFTC is misapplying the law. The CME argues that futures contracts must have an expiration date, whereas perpetual futures, also known as perps, are designed to allow traders to take a position on an asset's price without any deadlines. The CME believes this could harm its own long-dated futures products and is concerned about the potential consequences of the CFTC's sudden embrace of perps. The tension between the two entities has been escalating, with the CME attempting to fast-track 24/7 trading for crude oil futures, only to be blocked by the CFTC. The regulator's chairman, Mike Selig, has stated that the CME's decision to disregard the agency's efforts to analyze the issues at stake is 'wholly inappropriate.' The CME's chairman, Terry Duffy, has countered that the CFTC is not following protocol and may not be prepared to enforce its emerging perps policy properly. The dispute has significant implications for the US approach to the rapidly growing perps market, with non-US perps volume reportedly reaching $60 trillion in 2023. The case is being closely watched, with many viewing the CME's stance as an attempt to protect its dominance in the derivatives market. The outcome of the court battle could have far-reaching consequences for the development of on-chain markets in the US.